PACB 1.8 (+1.69%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

53 / 58

Performance 5 years

43 / 58

Performance 10 years

40 / 58

Linearity 3 years

46 / 58

Linearity 5 years

15 / 58

Linearity 10 years

12 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Performance 10 years - PACB ranking 40 / 58

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.33K
3. Medpace Holdings MEDP
1.1K
4. RadNet RDNT
877.16
5. Natera NTRA
829.22
6. DexCom DXCM
478.02
7. IDEXX Laboratories IDXX
462.85
8. Danaher DHR
319.79
9. Mettler-Toledo MTD
314.81
10. Thermo Fisher Scientific TMO
307.74
11. Icon ICLR
290.61
12. IQVIA Holdings IQV
247.97
13. PerkinElmer PKI
247.07
14. NeoGenomics NEO
242
15. Waters WAT
221.93
16. Twist Bioscience TWST
220.46
17. CareDx CDNA
218.03
18. Agilent Technologies A
215.36
19. Charles River Laboratories CRL
205.08
20. Laboratory Corp of America Holdings LH
176.92
21. Quest Diagnostics DGX
152.77
22. Exact Sciences EXAS
133.27
23. Syneos Health SYNH
113.83
24. Fulgent Genetics FLGT
84.04
25. Qiagen QGEN
72.55
26. Meridian Bioscience VIVO
60.69
27. Inotiv NOTV
51.56
28. National Research NRC
34.49
29. Ortho Clinical Diagnostics Holdings OCDX
13.74
30. Guardant Health GH
11.64
31. Neogen NEOG
-9.22
32. Illumina ILMN
-22.55
33. Bioventus BVS
-23.77
34. Olink Holding OLK
-26.82
35. Anixa Biosciences ANIX
-35.58
36. Myriad Genetics MYGN
-53.29
37. Sotera Health SHC
-54.04
38. Sera Prognostics SERA
-59.29
39. Global Cord Blood CO
-66.57
40. Pacific Biosciences of California PACB
-74.71
41. DarioHealth DRIO
-75.47
42. Exagen XGN
-76.67
43. Enzo Biochem ENZ
-77.8
44. MaxCyte MXCT
-79.69
45. Co-Diagnostics CODX
-82.33
46. Psychemedics PMD
-84.4
47. bioAffinity Technologies BIAF
-85.24
48. Personalis PSNL
-85.68
49. MDxHealth MDXH
-85.93
50. Biodesix BDSX
-91.17
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.31
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.47
56. Interpace Biosciences IDXG
-98.48
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.77
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.